RYOAX

Mutual Fund ticker: NASDAQ

PRICE

CHANGE

NET ASSETS

Rydex Biotechnology H (RYOAX) Ownership - Who owns Rydex Biotechnology H?

The investment seeks to provide capital appreciation... Show more

Category: #Health

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Details

Group

Domestic Stock Funds

Fundamentals

RYOAX

Net Assets

80.7M

Fund Existence

about 27 years

Turnover

51.00

Total Expense Ratio

1.65

Front Load

N/A

Manager

N/A

Manager Tenure

N/A

Min. Initial Investment

2500

Min. Initial Investment IRA

N/A

Morningstar Category

Health

Administrative Fee

N/A

Annual Report Gross Expense Ratio

1.68

Assets in Top Ten Holdings

46.1M

Average Credit Quality

N/A

Average Effective Duration

N/A

Average Effective Maturity

N/A

Fund of Funds

Fund Share Class Net Assets

3.85M

Fund Type

OpenEnd

Index Fund

Management Fee

0.85

Modified Duration

N/A

No Load Fund

Yes

Number of Long Holdings

79.00

Number of Net Holdings

81.00

Number of Short Holdings

2.00

Prospectus Acquired Expense Ratio

N/A

Weighting Top Ten Holdings

38.36%

Gain YTD

-6.716

Annual Yield % from dividends

0.00

Returns for 1 year

-16.71

Returns for 3 years

-16.94

Returns for 5 years

-34.93

Returns for 10 years

-46.30

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Category Health

Profile

Fundamentals

Details